National Health Investors (NYSE:NHI) Sets New 12-Month High – Time to Buy?

National Health Investors, Inc. (NYSE:NHI) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $81.19 and last traded at $81.16, with a volume of 29889 shares traded. The stock had previously closed at $79.70.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Wells Fargo & Company increased their price target on National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. Cantor Fitzgerald set a $85.00 target price on shares of National Health Investors in a research note on Monday, January 5th. National Bankshares set a $85.00 price objective on National Health Investors in a research note on Tuesday. Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a research note on Monday, December 29th. Finally, Truist Financial boosted their price target on shares of National Health Investors from $81.00 to $83.00 and gave the stock a “buy” rating in a research report on Monday, December 15th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $85.57.

National Health Investors Stock Up 0.6%

The company has a debt-to-equity ratio of 0.74, a current ratio of 10.64 and a quick ratio of 10.64. The firm has a market capitalization of $3.82 billion, a P/E ratio of 25.28, a price-to-earnings-growth ratio of 2.99 and a beta of 0.67. The business has a 50 day moving average price of $77.92 and a 200 day moving average price of $76.16.

National Health Investors (NYSE:NHI) last released its earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 EPS for the quarter, beating the consensus estimate of $1.24 by $0.08. The firm had revenue of $83.36 million during the quarter, compared to analysts’ expectations of $85.66 million. National Health Investors had a net margin of 41.38% and a return on equity of 10.17%. The business’s quarterly revenue was down 1.8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.03 EPS. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, analysts predict that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 4.6%. The ex-dividend date of this dividend is Wednesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is presently 116.09%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. GAMMA Investing LLC boosted its stake in National Health Investors by 41.8% during the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 136 shares in the last quarter. Assetmark Inc. boosted its position in shares of National Health Investors by 19.0% during the 2nd quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust’s stock valued at $65,000 after acquiring an additional 148 shares in the last quarter. Creative Planning increased its stake in National Health Investors by 2.2% in the second quarter. Creative Planning now owns 8,217 shares of the real estate investment trust’s stock valued at $576,000 after acquiring an additional 177 shares during the period. PNC Financial Services Group Inc. raised its position in National Health Investors by 5.0% in the third quarter. PNC Financial Services Group Inc. now owns 3,731 shares of the real estate investment trust’s stock worth $297,000 after purchasing an additional 177 shares in the last quarter. Finally, Aviance Capital Partners LLC raised its position in National Health Investors by 3.8% in the second quarter. Aviance Capital Partners LLC now owns 5,225 shares of the real estate investment trust’s stock worth $366,000 after purchasing an additional 189 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.